Wenxin Wu

Wenxin Wu

Auto-generated profile, based on publicly available information

Wenxin Wu

Department of Pathology, The Second Hospital of Hebei Medical University, Shijiazhuang City, Hebei Province, China

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2021 in Oncology Letters
Verified
Journal Article
Open access
PDF file
DLDan Li
Dan Li
YCYanan Cao
Yanan Cao
JWJuan Wang
Juan Wang
HYHaiyan Yang
Haiyan Yang
WLWeina Liu
Weina Liu
WWWenxin Wu
Wenxin Wu
Due to the high incidence of colorectal cancer worldwide, the underlying molecular mechanisms have been extensively investigated. The Wnt/β‑catenin signaling pathway plays a key role in the carcinogenesis of colorectal adenoma. In addition, the high mobility group AT‑hook 2 (HMGA2) protein, which is involved in several biological processes, such as proliferation, differentiation, transformation and metastasis, is expressed at significantly high levels in colorectal cancer tissues compared with adjacent normal tissues. Currently, the role of HMGA2 in the carcinogenesis of sporadic colorectal tubular adenoma remains unclear. The downstream Wnt/β‑catenin signaling molecule, T‑cell factor/lymphoid enhancing factor (TCF/LEF), shares a similar domain with HMGA2, which enhances β‑catenin transcriptional activity and TCF/LEF binding. Thus, the present study investigated the association between HMGA2 and the Wnt/β‑catenin signaling pathway, and their role in the carcinogenesis of sporadic colorectal tubular adenoma via immunohistochemistry, siRNA, quantitative PCR and western blot analyses. The results demonstrated that the positive rate of HMGA2 expression gradually increased during tumor progression. Furthermore, HMGA2 expression was positively correlated with Wnt/β‑catenin signaling protein expression [Wnt, β‑catenin, cyclin‑dependent kinase 4 (CDK4) and cyclin D1], suggesting its involvement in the carcinogenesis of sporadic colorectal tubular adenoma and its potential to synergistically interact with the Wnt/β‑catenin signaling pathway. HMGA2 knockdown in the human colorectal cancer cell line, HCT 116 decreased β‑catenin expression and its downstream targets, CDK4 and cyclin D1. Furthermore, silencing of Wnt or β‑catenin decreased HMGA2 expression. Taken together, the results of the present study suggest the coordinated regulation of HMGA2 and the Wnt/β‑catenin signaling pathway in the carcinogenesis of sporadic colorectal tubular adenoma.

16 August 2024 in Medicine
Verified
Journal Article
Open access
ZHZengfang Hao
Zengfang Hao
HCHanjing Cui
Hanjing Cui
YLYuehong Li
Yuehong Li
WWWenxin Wu
Wenxin Wu
YWYuan Wang
Yuan Wang
PZPengxin Zhao
Pengxin Zhao
Background: Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer, the coexistence of PTC and medullary thyroid carcinoma (MTC) is uncommon. While the simultaneous occurrence of both cancers with small lymphocytic lymphoma (SLL) in lymph nodes with PTC metastasis is very rare. This study presents a unique case of concurrent PTC, MTC, and SLL, highlighting the exceptional rarity of these coexisting tumors. Methods: A 75-year-old female with a thyroid tumor underwent total thyroidectomy, bilateral central neck lymph node dissection, and right radical neck lymph node dissection. Histopathological examination revealed a low-grade medullary thyroid carcinoma (MTC) in the left lobe and classical papillary thyroid carcinoma (PTC) in the right lobe, with PTC metastasis in the cervical lymph nodes and concurrent SLL in the affected lymph nodes. Results: Coexistence of PTC, MTC and SLL in the same patient is rare, there are currently no standardized treatment guidelines due to the limited literature. However, it is essential to consider not only the treatment for each type of tumor but also the potential risks or conflicts associated with the treatments. In the case reported in this paper, the papillary carcinoma invaded the capsule of the right lobe of the thyroid and metastasized to the cervical lymph nodes, warranting radioactive iodine therapy. However, considering the potential negative impact of radioactive iodine on the pre-existing lymphoma, the radioactive iodine therapy was postponed. Meanwhile, constant monitoring of calcitonin and thyroid globulin should be performed to monitor tumor recurrence as was performed in the present case. Conclusion: Since MTC, PTC, and SLL may coexist, patients with PTC deserve careful surveillance for the other disease entities. This case underscores the need for heightened awareness among clinicians, radiologists, and pathologists regarding the possibility of concurrent thyroid tumors and abnormal lymph nodes, guiding comprehensive pre-operative evaluations and postoperative monitoring strategies. This study aims to provide a warning for routine pathological diagnosis and contribute data for related research.

14 March 2014 in Tumor Biology
Verified
Journal Article
Closed access
PDF file
LWLinna Wang
Linna Wang
DLDan Li
Dan Li
YLYang Liu
Yang Liu
YWYuan Wang
Yuan Wang
JCJinfeng Cui
Jinfeng Cui
WWWenxin Wu
Wenxin Wu

1 September 2010
Verified
Journal Article
Closed access
WWWen-Xin Wu
Wen-Xin Wu
YDYin-Yan Duan
Yin-Yan Duan
GLGui-Hua Lü
Gui-Hua Lü
SSShu-Fen Shi
Shu-Fen Shi
JZJie-Ying Zhang
Jie-Ying Zhang
XZXiang-Hong Zhang
Xiang-Hong Zhang